EnerSys (ENS) Stock News

A class action lawsuit has been filed against The Ensign Group, Inc. (NASDAQ: ENSG) alleging systematic neglect of elderly patients, fraudulent Medicaid/Medicare claims, and record falsification. The allegations emerged following a June 2026 investigative report by Hunterbrook Media, which resulted in an 8.15% stock price decline. Investors with losses are urged to seek lead plaintiff status by December 7, 2026.

Vallourec, a global leader in premium tubular solutions, will showcase its VAM® connections and expanded CLEANWELL® grease-free solution at ADIPEC 2026 in Abu Dhabi (November 2-5, 2026). The company will present advanced offerings including VAM® 21, VAM® HTTC, VAM® SPRINT-TC for unconventional applications, and Delphy, its hydrogen underground storage solution, alongside engineering and operational services.

Vallourec, a world leader in premium seamless tubular solutions, will showcase its VAM® portfolio and expanded CLEANWELL® dope-free solution at ADIPEC 2026 in Abu Dhabi (November 2-5, 2026). The company will present VAM® 21, VAM® HTTC connections, VAM® SPRINT-TC for unconventional applications, and Delphy, its hydrogen storage solution, alongside Vallourec® Services offerings.

Rosen Law Firm has filed a securities class action lawsuit against The Ensign Group, Inc. on behalf of investors who purchased securities between February 10, 2022 and June 18, 2026. The lawsuit alleges that Ensign made false and misleading statements regarding its business practices, including systematic neglect of elderly residents, fraudulent Medicaid/Medicare billing, falsification of nursing assistant hours, and illegal licensing schemes. Investors who wish to serve as lead plaintiff must file by December 7, 2026.

Rosen Law Firm has filed a securities class action lawsuit against The Ensign Group, Inc. (NASDAQ: ENSG) on behalf of investors who purchased securities between February 10, 2022 and June 18, 2026. The lawsuit alleges that Ensign made false and misleading statements regarding its business practices, including systematic neglect of elderly residents, inadequate care, Medicare/Medicaid fraud, falsification of staffing records, and illegal licensing schemes. The firm is seeking lead plaintiffs with a deadline of December 7, 2026.

A securities class action lawsuit has been filed against The Ensign Group, Inc. on behalf of investors who purchased shares between February 10, 2022 and June 18, 2026. The lawsuit alleges that the company made materially false and misleading statements regarding its business operations, growth prospects, and financial stability, causing securities to trade at artificially inflated prices. Investors who suffered losses are encouraged to contact Bernstein Liebhard LLP, with a lead plaintiff deadline of December 7, 2026.

A securities class action lawsuit has been filed against The Ensign Group, Inc. for allegedly failing to disclose systematic neglect of elderly residents in its facilities, including inadequate food, medical attention, and basic care. The complaint also alleges fraud involving Medicaid and Medicare funds, falsification of nursing assistant hours, and illegal licensing schemes. The class period covers purchases between February 10, 2022 and June 18, 2026.

Rosen Law Firm has filed a class action lawsuit against The Ensign Group, Inc. (NASDAQ: ENSG) on behalf of investors who purchased securities between February 10, 2022 and June 18, 2026. The lawsuit alleges that Ensign made false and misleading statements regarding its business practices, including systematic neglect of elderly residents, fraudulent Medicaid/Medicare billing, falsification of nursing assistant hours, and illegal licensing schemes. Investors who purchased during the class period may be entitled to compensation. The deadline to serve as lead plaintiff is December 7, 2026.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of taxpayer funds to executives. Ensign's stock fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

EnerSys (ENS) is significantly outperforming its Industrial Products peers with a year-to-date return of 33.8% compared to the sector average of 14.6%. The company holds a Zacks Rank #2 (Buy) with improved analyst sentiment, as consensus earnings estimates have increased 10.8% in the past quarter. Kennametal (KMT) is also highlighted as an outperformer with a 14.8% year-to-date return and a stronger Zacks Rank #1 (Strong Buy) rating.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care and gaming quality metrics. The allegations claim profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates, with patients suffering and dying as a result. Ensign Group's stock fell 8.15% on June 8, 2026, following the report's publication.

Hagens Berman has filed a securities fraud class action lawsuit against HDFC Bank Limited and its executives, alleging the bank concealed a scheme involving approximately Rs 45 crore ($4.7 million USD) in disguised payments to induce state deposits while providing above-market interest rates. The fraudulent practices allegedly violated RBI regulations and the bank's internal policies, resulting in overstated financials. The scheme surfaced following the resignation of the Chairman in March 2026 and an investigative report in May 2026, causing HDFC's stock to decline sharply. The class period covers July 17, 2023 to May 26, 2026, with a lead plaintiff deadline of October 13, 2026.

A comparison of two Manufacturing-Electronics stocks reveals that EnerSys (ENS) presents a better value opportunity than ABB (ABBNY) for value investors. ENS has a stronger Zacks Rank (#2 Buy vs #3 Hold), lower valuation multiples (P/E of 13.51 vs 25.28, PEG of 0.90 vs 1.41), and a superior Value grade (A vs D).

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. after short seller Hunterbrook released a report alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of taxpayer funds to executives. The allegations caused Ensign's stock to fall 8.15% on June 8, 2026. The firm is preparing a class action lawsuit to recover investor losses.

The Rosen Law Firm is investigating potential securities fraud claims against The Ensign Group, Inc. after short seller Hunterbrook released a report alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of taxpayer funds to executives. The allegations caused Ensign's stock to fall 8.15% on June 8, 2026. The firm is preparing a class action lawsuit to recover investor losses.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short-seller report by Hunterbrook alleging the nursing home operator engaged in poor patient care and quality metric manipulation. The report claimed company profits depended on understaffing and misappropriation of funds to executives, resulting in patient suffering and deaths. Ensign's stock declined 8.15% on June 8, 2026, following the disclosure.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misuse of taxpayer funds. The allegations caused Ensign's stock to fall 8.15% on June 8, 2026. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of funds. Ensign's stock fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of taxpayer funds to executives. Ensign shares fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

Rosen Law Firm is investigating The Ensign Group, Inc. (NASDAQ: ENSG) for potentially issuing materially misleading business information to investors. The investigation was triggered by a short-seller report from Hunterbrook alleging that Ensign's profitability model relies on reducing patient care quality and manipulating quality scores. Following the report's release on June 8, 2026, Ensign's stock price declined 8.15%. The firm is preparing a class action lawsuit and inviting affected investors to join.

The Rosen Law Firm is investigating potential securities claims against The Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care, understaffing, and misrouting of funds. Ensign shares fell 8.15% on June 8, 2026, following the report's publication. The firm is preparing a class action lawsuit to recover investor losses.

Pomerantz LLP is investigating The Ensign Group for potential securities fraud following short reports from Hunterbrook and Muddy Waters Research alleging inadequate patient care, understaffing, quality metric manipulation, and possible Medicare/Medicaid fraud. The allegations triggered significant stock price declines of 8.15% and 2.98% on consecutive trading days in June 2026.

Eva Live Inc. (NASDAQ: GOAI) announced a Letter of Intent to acquire a controlling 51% interest in Airbeam Wireless Technologies for approximately $16 million, with an option to acquire the remaining 49%. The acquisition provides access to over 260 patents and advanced millimeter-wave semiconductor technology built on more than $150 million in cumulative R&D investment. Eva Live aims to combine Airbeam's wireless technology with its AI platform to develop next-generation communications for autonomous drone swarms, resilient military networks, smart cities, and satellite infrastructure, targeting a $3 trillion global opportunity.

Law firm Lowey Dannenberg is investigating The Ensign Group for potential federal securities law violations following short-seller reports alleging systemic quality-measure gaming, falsified care-quality data, improper related-party billing, and possible Medicare/Medicaid fraud. The allegations caused significant stock price declines and shareholder losses.

The Rosen Law Firm is investigating potential securities claims against Ensign Group, Inc. following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care and gaming quality metrics. The report claims profits depend on understaffing facilities while routing taxpayer dollars to executives. Ensign shares fell 8.15% on June 8, 2026, following the report's publication.

Pomerantz LLP is investigating The Ensign Group for potential securities fraud following short reports from Hunterbrook and Muddy Waters Research alleging inadequate patient care, understaffing, quality metric manipulation, and possible Medicare/Medicaid fraud. The allegations triggered significant stock price declines of 8.15% and 2.98% on consecutive trading days in June 2026.

Law firm Robbins Geller Rudman & Dowd LLP has launched an investigation into The Ensign Group, Inc. following a Muddy Waters Research report alleging deception at approximately 20% of facilities with potential multi-billion dollar liability. The report triggered a decline in Ensign's stock price. The firm is seeking investors and witnesses with information about potential federal securities law violations.

The Ensign Group (ENSG) stock fell over 8% after Hunterbrook Media and Muddy Waters Research published critical reports alleging the company cuts staff at acquired nursing facilities while claiming quality improvements, and potentially engages in fraudulent practices involving rented nursing home administrator licenses. The allegations have wiped out over $500 million in market capitalization, prompting Hagens Berman to investigate potential securities law violations.

The Rosen Law Firm is investigating potential securities claims on behalf of Ensign Group shareholders following a short seller report by Hunterbrook alleging the nursing home operator's business model relies on inadequate patient care and gaming quality metrics. The allegations claim profits depend on understaffing facilities while routing taxpayer dollars to executives. Ensign shares fell 8.15% on June 8, 2026, following the report's publication.

Lowey Dannenberg P.C. is investigating The Ensign Group (NASDAQ: ENSG) for potential violations of federal securities laws following short-seller reports alleging systemic quality-measure gaming, falsified care-quality data, improper related-party billing, and possible Medicare/Medicaid fraud. The allegations caused significant stock price declines and shareholder losses.